Literature DB >> 1649812

A case of cervical carcinoma of the uterus presenting with hyperosmolar non-ketotic coma as a manifestation of ectopic adrenocorticotropic hormone syndrome.

Y Shirahige1, T Watanabe, Y Oki, T Sonoda, I Adachi.   

Abstract

A case of advanced cervical carcinoma of the uterus with ectopic adrenocorticotrophic hormone (ACTH) syndrome is described. The patient was seen for general malaise 21 months after surgical treatment of the primary lesion whose histology was undifferentiated small cell carcinoma of the uterine cervix. She had extensive metastases in the liver and the abdominal wall. In addition to the typical clinical manifestations of Cushing's syndrome such as moon face, central obesity and acne vulgaris, hyperglycemia was so severe that she was in a hyperosmolar non-ketotic coma. Endocrinological examinations revealed elevated plasma ACTH and cortisol, and urinary excretion of 17-hydroxycorticosteroids and 17-ketosteroids, which were not suppressed by high-dose dexamethasone administration. Based on these clinical and laboratory findings, a diagnosis of ectopic ACTH syndrome was made. Among the results of other endocrinological examinations conducted to find the etiological cause of the hyperglycemic coma, which seemed to be unusual for ectopic ACTH syndrome, the plasma somatostatin level was abnormally high. Metastatic tumors in the liver obtained at the time of autopsy contained large amounts of both ACTH and somatostatin, and gel filtration studies revealed that the peptides produced by the tumor had the molecular sizes of the biologically active forms of the respective peptides. These observations suggest possible involvement of the somatostatin in deteriorating glucose intolerance to develop hyperglycemic hyperosmolar non-ketotic coma as a drastic disturbance of metabolism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1649812      PMCID: PMC5918500          DOI: 10.1111/j.1349-7006.1991.tb01907.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  34 in total

1.  Somatostatin: hypothalamic inhibitor of the endocrine pancreas.

Authors:  D J Koerker; W Ruch; E Chideckel; J Palmer; C J Goodner; J Ensinck; C C Gale
Journal:  Science       Date:  1974-04-26       Impact factor: 47.728

2.  Letter: Hyperosmolar coma in Cushing's disease.

Authors:  P Kandall-Taylor
Journal:  Lancet       Date:  1974-03-09       Impact factor: 79.321

3.  Inhibition of insulin secretion by somatostatin.

Authors:  K G Alberti; N J Christensen; S E Christensen; A P Hansen; J Iversen; K Lundbaek; K Seyer-Hansen; H Orskov
Journal:  Lancet       Date:  1973-12-08       Impact factor: 79.321

4.  Diagnostic and therapeutic implications of ectopic hormone production in small cell carcinoma of the lung.

Authors:  M Hansen; M Hammer; L Hummer
Journal:  Thorax       Date:  1980-02       Impact factor: 9.139

5.  Immunoreactive endorphins, lipotropins and corticotropins in a human nonpituitary tumor: evidence for a common precursor.

Authors:  D N Orth; R Guillemin; N Ling; W E Nicholson
Journal:  J Clin Endocrinol Metab       Date:  1978-05       Impact factor: 5.958

6.  Effect of sodium valproate on the secretion of proopiomelanocortin derived peptides from cultured rat anterior pituitary cells.

Authors:  T Tominaga; Y Oki; I Tanaka; Y Ikeda; M Nanno; T Yoshimi
Journal:  Endocrinol Jpn       Date:  1989-12

7.  Somatostatin secretion by lung and thymic tumours.

Authors:  E Penman; J A Wass; G M Besser; L H Rees
Journal:  Clin Endocrinol (Oxf)       Date:  1980-12       Impact factor: 3.478

8.  Identification of adenylate cyclase-stimulating activity and cytochemical glucose-6-phosphate dehydrogenase-stimulating activity in extracts of tumors from patients with humoral hypercalcemia of malignancy.

Authors:  A F Stewart; K L Insogna; D Goltzman; A E Broadus
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

9.  Insulin, glucagon, and somatostatin in normal physiology and diabetes mellitus.

Authors:  P Felig; J Wahren; R Sherwin; R Hendler
Journal:  Diabetes       Date:  1976-12       Impact factor: 9.461

10.  Pancreatic somatostatinoma. Clinical features and physiological implications.

Authors:  L I Larsson; M A Hirsch; J J Holst; S Ingemansson; C Kühl; S L Jensen; G Lundqvist; J F Rehfeld; T W Schwartz
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

View more
  2 in total

1.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

2.  Utility of [(18)F] fluoro-2-deoxy-D: -glucose positron emission tomography in the localization of ectopic ACTH-secreting tumors.

Authors:  Aline Barbosa Moraes; Giselle F Taboada; Michel Pontes Carneiro; Leonardo Vieira Neto; Luiz Eduardo Armondi Wildemberg; Kalil Madi; Romeu Cortes Domingues; Mônica R Gadelha
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.